Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Lincoln Pharmaceuticals Ltd reports Net Profit of Rs. 50.03 crore in H1 FY25, growth of 7.55 Percent Y-o-Y Business
  • Apex Professional University Hosts AIU Anveshan 2025 – East Zone Student Research Convention Education
  • Laththi second look out- Action galore on the way Entertainment
  • Jaideep G. Mirchandani- Chairman of Group Sky One FZE – A Visionary Leader in Global Aviation Business
  • “IPS Academy Indore Hosts Graduation Ceremony; Students Felicitated with Academic Excellence Awards” Education
  • K-Pop Demon Hunters 2025: Netflix’s Record-Smashing Animated Obsession That Fans Can’t Stop Talking About Entertainment
  • PUREXA Unveils India’s Sole Herbal Gum Serum, Pioneering Oral Wellness with Natural Efficacy Business
  • Jogani Reinforcement’s Basalt and Brass Coated Fibers appreciated with Product of the Year at WOC India 2024 Lifestyle

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Zyla Health welcomes Amar Sinhji on the board of advisors to drive innovation and strategic growth Health
  • Vista Imaging, Medikabazaar and United Imaging Bring India’s First & Most Advanced 640-Slice AI Powered CT Scanner to Hyderabad Health
  • Swasth Hriday Ignites Digital Transformation Dialogue at HEALTHTECH 2025 in Vapi Health
  • The Top 5 Men Often Lack in Their Diet Health
  • Bone & Joint Day 2025: Expert Advice on Prevention, Early Care & Mobility Health Health
  • Leading IVF Center in Nagpur: Aansh Hospital and IVF Center by Dr. Shweta Agarwal Health

Recent Posts

  • They Lost Everything at 30. Twelve Months Later, They Built a Rs 1 Crore Empire from Scratch
  • Dr. RVR NRIU Attains Deemed-to-be University Status, Expands Vision for Global Education Excellence
  • Dr. Arpit Chopra Jain Represents India at Prestigious International Forums in Sri Lanka, Japan, and New Delhi
  • The Warning Signs Were There; Nobody Was Looking
  • IIT Delhi Invites Applications for Second Batch of Online PG Diploma in Healthcare Product Development and Management

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • India’s development, Inclusion and Environmental Stewardship at UNHRC Lifestyle
  • Winter Notes of Author Soma Bose Lifestyle
  • Sanjeevana Institute – Helping graduates get market-ready Business
  • Trident Lifeline brings its IPO of ₹35.34 Crore on the 26th September, To be listed on BSE SME Business
  • AGM and GVBO Master Meet organised to mark Panchal Youth Organization’s Foundation Day  Business
  • Yash Ahlawat Makes His Debut in Regional Cinema with ‘Pratha’ Entertainment
  • Vice President Jagdeep Dhankar Presents the 25th Lal Bahadur Shastri National Award to Rajashree Birla National
  • Goldenflitch at 5: Arka Baidya Brings Founders, Investors, and Product Leaders Together at the Frontier of AI-Driven Product Design Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme